FMCNAFresenius Medical Care North America
FMCNAFree Methodist Church of North America
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
8 May 2019 - US-based dialysis products and services provider Fresenius Medical Care North America (FMCNA), the nation's provider of kidney care products and services, has announced organisational changes following its USD 2bn acquisition of NxStage Medical, Inc., the company said.
As part of these changes, Jeff Burbank and Joe Turk have joined the FMCNA senior leadership team in new roles that will help lead the company's innovation and expansion of home therapies.
Burbank, former NxStage Founder and chief executive officer, will serve as the company's first chief technology officer, reporting to Bill Valle, CEO of FMCNA.
Turk, who previously served as president at NxStage, will also report to Valle as president of Home and Critical Care Therapies, leading a newly formed team within FMCNA.
As CTO, Burbank will help grow FMCNA's innovative product offerings and connected health platforms.
"We strive to treat the whole patient -- not just their condition -- and recognize the unique role we can play in furthering the national dialogue around chronic kidney disease and transplant awareness," said Bill Valle, FMCNA Chief Executive Officer and President of the Fresenius Medical Care Foundation.
In addition, FMCNA donated $50,000 to the YMCA of Metropolitan Chicago toward summer camp support, including Camp Duncan, which in part focuses on children with diabetes.
For more information, visit the FMCNA website at
"We created this name to better com municate our approach to helping people with kidney disease thrive and continue doing the things that matter most to them," said William Valle, executive vice president of FMCNA and president of Fresenius Kidney Care.
"At FMCNA, we are building a network to provide the full spectrum of care for the chronically ill, including those with renal disease," said Ron Kuerbitz, CEO of Fresenius Medical Care North America.
FMCNA claims to be the world's largest fully integrated renal company, offering specialty pharmacy and laboratory services.
All study data were obtained from the FMCNA Knowledge Center data warehouse and were collected according to standard clinical protocols [8].